In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report). The company’s ...
Dyne Therapeutics Inc. 4.43% $1.38B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback